The use of antibiotics during pregnancy cannot always be avoided.
Researchers investigating the impact of antibiotic use on the health of premature infants recently published their findings in the Journal of Pediatrics.
Babies born prematurely are extremely vulnerable even in the protective environment provided by neonatal intensive care units.
Approximately 33% of infants born before 32-weeks gestation develop late-onset sepsis (LOS), which occurs when the bloodstream becomes infected with bacteria.
Fewer infants (7%) develop necrotizing enterocolitis (NEC), a serious condition with a relatively high mortality rate in which sections of the bowel die.
Past studies suggested that the risk of developing these diseases, or even dying, is increased in premature infants who are given antibiotics for an extended period from birth.
Antibiotics during pregnancy can affect an infant’s microbial population
An emerging concern is that infants are developing infections that are resistant to the antibiotics taken by their mothers during pregnancy. This prompted a team in the USA to ask whether fetal exposure to antibiotics during pregnancy could increase the incidence of post-birth bacterial infections, such as LOS and NEC, in premature babies.
The team gathered data from 580 infants born before 32 weeks gestation.
These infants had been placed into one of three level-III neonatal intensive care units in Ohio or Alabama in the United States. They were monitored for 120 days or until they were discharged, transferred, or died.
The results, published in the Journal of Pediatrics, found that 21.3% of these infants were affected by NEC (7.5%), LOS (11.1%), or died (9.6%). Factors including birth weight, gestational age, sex, race, or duration of breastfeeding did not affect these results.
Antibiotics during pregnancy may have a protective effect
When the team compared antibiotic use during pregnancy with the risk of developing NEC or LOS, or the risk of death, they found that 62.4% of infants were exposed to at least one antibiotic during pregnancy.
Antibiotic use during pregnancy was defined as the administration of any antibiotics within 72 hours of delivery.
Mothers who were given antibiotics at delivery or during a cesarean delivery were excluded as the administration at these points in time was not expected to affect the baby.
Contrary to expectations, the team found that using antibiotics during pregnancy actually reduced the risk of NEC and infant death by three-fold. However, there was a non-significant 1.6-fold increase in the risk of LOS. The team were unable to determine why the risk for LOS alone increased, and suggest that this should be investigated further.
Antibiotics administered after birth increase the risk of death
The team also looked at whether antibiotics administered to infants from birth had an impact on NEC, LOS, or death.
They found that 23.2% of the babies had high post-natal exposure to antibiotics, that is, they had received antibiotics for more than five continuous days from birth. These infants were also more likely to have been exposed to antibiotics during pregnancy.
Notably, the team found that high post-natal exposure to antibiotics increased the odds of death three-fold, but had no impact on NEC or LOS.
It is possible that exposure to antibiotics during pregnancy contributed to antibiotic-resistant bacterial infections in this subgroup of infants.
Further studies into the effects of antibiotics on microbial populations are required
This study highlights the importance of understanding how antibiotics influence the interactions between maternal and infant microbial populations.
This information will prove highly valuable for clinicians when selecting antibiotics for use in highly vulnerable premature infants.
However, the authors emphasize that microbial populations vary depending on geographical and temporal differences and even our ethnic origin; therefore, the same results may not be seen in other populations.
Written by Natasha Tetlow, PhD
Reference: Reed B, et al. The impact of maternal antibiotics on neonatal disease. J Pediatr. 2018. 197: 97-103.